BHC
BHC
NYSE · Pharmaceuticals

Bausch Health Cos Inc

$5.08
+0.09 (+1.80%)
As of Mar 25, 8:55 PM ET ·
Analyst Consensus
Strong Sell
9
Analysts
Moderate
Coverage
Buy 0 0%
Hold 5 56%
Sell 4 44%
Price Target
Analyst Price Target +1,942.9% upside
Low Target $65.08
Average Target $103.78
High Target $115.24
Current Price $5.08
Current
$5.08
Target
$103.78
$65.08 $103.78 avg $115.24
Scenario Analysis
Bear Case
$65.08
1,181.1%
Low target
Base Case
$103.78
+1,942.9%
Avg target
Bull Case
$115.24
+2,168.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$11.97
-57.6% from high
52-Week Low
$5.91
+-14.0% from low
50-Day SMA
$6.64
-23.5% vs SMA
200-Day SMA
$6.36
-20.1% vs SMA
RSI (14)
60.0
Neutral
Target vs 52W High
$103.78
+767.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%